Suppr超能文献

利用超临界抗溶剂(SAS)工艺提高难溶性药物的溶解度和生物利用度。

Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process.

机构信息

College of Pharmacy, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea; Yonsei Institute of Pharmaceutical Sciences, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea.

College of Pharmacy, Pusan National University, 63 beon-gil 2 Busandaehak-ro, Geumjeong-gu, Busan, 46241, Republic of Korea.

出版信息

Int J Pharm. 2018 Mar 1;538(1-2):1-13. doi: 10.1016/j.ijpharm.2017.12.041. Epub 2017 Dec 24.

Abstract

Poor water solubility and poor bioavailability are problems with many pharmaceuticals. Increasing surface area by micronization is an effective strategy to overcome these problems, but conventional techniques often utilize solvents and harsh processing, which restricts their use. Newer, green technologies, such as supercritical fluid (SCF)-assisted particle formation, can produce solvent-free products under relatively mild conditions, offering many advantages over conventional methods. The antisolvent properties of the SCFs used for microparticle and nanoparticle formation have generated great interest in recent years, because the kinetics of the precipitation process and morphologies of the particles can be accurately controlled. The characteristics of the supercritical antisolvent (SAS) technique make it an ideal tool for enhancing the solubility and bioavailability of poorly water-soluble drugs. This review article focuses on SCFs and their properties, as well as the fundamentals of overcoming poorly water-soluble drug properties by micronization, crystal morphology control, and formation of composite solid dispersion nanoparticles with polymers and/or surfactants. This article also presents an overview of the main aspects of the SAS-assisted particle precipitation process, its mechanism, and parameters, as well as our own experiences, recent advances, and trends in development.

摘要

许多药物都存在水溶性差和生物利用度低的问题。通过微粉化来增加表面积是克服这些问题的有效策略,但传统技术通常使用溶剂和苛刻的处理条件,限制了它们的应用。较新的绿色技术,如超临界流体(SCF)辅助颗粒形成,可以在相对温和的条件下生产无溶剂产品,与传统方法相比具有许多优势。近年来,用于微颗粒和纳米颗粒形成的 SCF 的抗溶剂特性引起了极大的兴趣,因为沉淀过程的动力学和颗粒的形态可以得到精确控制。超临界抗溶剂(SAS)技术的特点使其成为提高难溶性药物溶解度和生物利用度的理想工具。本文综述了 SCF 及其性质,以及通过微粉化、控制晶体形态和与聚合物和/或表面活性剂形成复合固体分散纳米颗粒来克服难溶性药物性质的基本原理。本文还介绍了 SAS 辅助颗粒沉淀过程的主要方面、其机制和参数,以及我们自己的经验、最新进展和发展趋势。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验